TVTX (TVTX) Stock Price & Analysis
TVTX (TVTX) rose 0.00% to USD 57.36 as of July 25, 2026 at 02:22 UTC, according to Nexqual real-time market data.
TVTX last closed at USD 57.36; the session ranged USD 56.26–57.62 on volume of 1,228,555 shares. Market capitalization is —, with a 52-week range of USD 15.03–60.1 (NGM). Source: Nexqual, July 25, 2026 at 02:22 UTC.
Key Statistics (as of July 25, 2026 at 02:22 UTC)
| Price | USD 57.36 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 57.36 |
| Open | USD 57.36 |
| Day Range | USD 56.26 – 57.62 |
| 52-Week Range | USD 15.03 – 60.1 |
| Volume | 1,228,555 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TVTX)
Nexqual's technical model rates TVTX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 02:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.91 (neutral) |
| vs SMA50 | Above (USD 51.78) |
| MACD | 1.2 (positive) |
From TVTX's Latest SEC 10-K Filing (filed 2026-02-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | USD 113.03 | ▼ 1.27% |
| VRDN | Viridian Therapeutics, Inc. | USD 19.27 | ▲ 0.52% |
| ARQT | Arcutis Biotherapeutics, Inc. | USD 27.35 | ▼ 1.97% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 83.73 | ▲ 0.01% |
| KYMR | Kymera Therapeutics, Inc. | USD 110.57 | ▲ 0.21% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:22 UTC. This page is informational and not investment advice.